News Industry News NanoCor Therapeutics Announces FDA Acceptance of Investigational New Drug (IND) for Carfostin® April 20, 2016
News Industry News Renova Therapeutics expands robust gene therapy intellectual property portfolio for cardiovascular and metabolic disease treatments January 03, 2016